Results 41 to 50 of about 9,802 (262)

Conservative Surgical Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw with Er,Cr:YSGG Laser and Platelet-Rich Plasma: A Longitudinal Study [PDF]

open access: yes, 2018
Introduction: The management of bisphosphonate-related osteonecrosis of the jaw (BRONJ), with no evidence-based guidelines, remains controversial. We aimed to evaluate the efficiency of a conservative surgical treatment combining Er,Cr:YSGG laser and ...
Albanese, Antonino   +10 more
core   +1 more source

Microscopic Evaluation of the Effect of Oral Microbiota on the Development of Bisphosphonate-Related Osteonecrosis of the Jaws in Rats

open access: yeseJournal of Oral Maxillofacial Research, 2017
Objectives: Osteonecrosis of the jaws is a side effect associated with the use of bisphosphonates. Using histologic analysis, this study aimed to evaluate the influence of microbial colonies in the development of osteonecrosis in the jaws of rats ...
Felipe M. Silveira   +3 more
doaj   +1 more source

Cost-utility of adjuvant zoledronic acid in patients with breast cancer and low estrogen levels [PDF]

open access: yes, 2015
BACKGROUND: Adjuvant zoledronic acid (za) appears to improve disease-free survival (dfs) in women with early-stage breast cancer and low levels of estrogen (lle) because of induced or natural menopause.
Lamond, Nathan W D   +3 more
core   +1 more source

Dental Implant Placement in Patients on Bisphosphonate Therapy: a Systematic Review

open access: yeseJournal of Oral Maxillofacial Research, 2018
Objectives: The review aims to study dental implant placement purposefulness for patients who have been treated or are on treatment with bisphosphonate medication.
Rokas Gelazius   +4 more
doaj   +1 more source

Bisphosphonate-Related Osteonecrosis of the Jaw Mimicking Bone Metastasis

open access: yesCase Reports in Oncological Medicine, 2014
Osteonecrosis of the jaw is usually a potential complication of bisphosphonate therapy. In a cancer patient, this disease entity can be misdiagnosed as a metastatic lesion. Our aim is to make clinicians aware of bisphosphonate associated osteonecrosis of
Geetika Bhatt   +4 more
doaj   +1 more source

Quantitative indices for cone-beam CT assessment of Medication-Related Osteonecrosis of the Jaw – a scoping review

open access: yesSaudi Dental Journal, 2023
Objectives: It is not unusual for Medication-related osteonecrosis of the jaw (MRONJ) lesions that have similar clinical presentation and staging to have dissimilar radiographic extent of disease.
Ghaidaa Badabaan   +4 more
doaj   +1 more source

Osteonecrosis of the jaws in patients treated with bisphosphonates [PDF]

open access: yes, 2012
The literature describes an increasing presence of bisphosphonate-induced osteonecrosis of the jaws (ONJ), characterized by the exposure for over 8 weeks of necrotic bone in the maxillofacial region, after bisphosphonate therapy, in the absence of ...
Ata-Ali Mahmud, Fadi   +3 more
core   +1 more source

Fatal infectious encephalitis as a complication of medication-related osteonecrosis of the jaw

open access: yesOral and Maxillofacial Surgery Cases, 2020
We present a unique case of bacterial encephalitis in a 79-year-old female due to progression of medication-related osteonecrosis of the jaw. The occurrence of this life-threatening neurologic condition following the expansion of medication-related ...
Hye-Won Kim   +3 more
doaj   +1 more source

Novel modified quantitative index for cone-beam CT assessment of medication-related osteonecrosis of the jaw - comparative analysis with original index

open access: yesSaudi Dental Journal, 2023
Purpose: The main research goal was to address the critical need for an objective and quantitative index to describe the nature and extent of radiographic features of medication-related osteonecrosis of the jaw (MRONJ) lesions and complement the ...
Ghaidaa Badabaan   +4 more
doaj   +1 more source

Sinusitis and oroantral fistula in patients with bisphosphonate-associated necrosis of the maxilla [PDF]

open access: yes, 2016
BACKGROUND: The management of bisphosphonate related necrosis of the jaw has become clinical routine. While approximately two thirds of the lesions are in the mandible, one third is located in the maxilla.
Andres Stricker   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy